Pharmacy Department

Pharmacy Services

Distributive Services
Drug Distribution Services include concurrent drug use review; preparation and distribution of sterile and non-sterile products; and investigational drug dispensing to inpatients and ambulatory patients.

Clinical Programs
Clinical Programs include participation in drug selection and experimental protocol design and implementation; monitoring patient response to drug therapy; patient education; provision of drug information; drug use evaluation; and patient counseling.=

Investigational Drug Management
Investigational Drug Management includes protocol support activities, investigational drug information development, and control and accountability of investigational agents.

FDA Observations and Clinical Center Responses
FDA Inspection Observations Form 483 (February / March 2019)

Response to FDA 483, FEI #3011547221

FDA Inspection Observations Form 483 (May / June 2015)

NIH Interim Corrective Action Plan in Response to Inspectional Observations of the NIH Clinical Center Pharmaceutical Development Section Dated June 2, 2015

NIH Interim Corrective Action Plan in Response to Inspectional Observations Dated May 29, 2015 of the NIH Clinical Center Pharmacy

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 12/08/2022

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at